• Explore /
  • Poster
  • / Final report of a pilot trial combining ipilimumab and adoptive cell therapy.

Final report of a pilot trial combining ipilimumab and adoptive cell therapy.

Abstract Poster

Authors

John Mullinax

John Mullinax

H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

John Mullinax, Jeffrey S. Weber, Nikhil I. Khushalani, Zeynep Eroglu, Andrew Scott Brohl, Joseph Markowitz, Erica Royster, Allison Richards, Jonathan S. Zager, Vernon K. Sondak, James J Mule', Shari Pilon-Thomas, Amod Sarnaik

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells

Sub Track

Adoptive T-cell therapy: Modified and Unmodified Cells

Clinical Trial Registration Number

NCT01701674

Citation

J Clin Oncol 35, 2017 (suppl 7S; abstract 147)

DOI

10.1200/JCO.2017.35.7_suppl.147

Abstract #

147

Poster Bd #

G6

Abstract Disclosures

Similar Posters

First Author: Marie-Andree Forget

First Author: Svetomir Markovic

First Author: Jeffrey Thomas Yorio

First Author: Rongsu Qi